Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Alexandra Lauré
Side Effects for PE Amid Changing EU Life Sciences and Healthcare Landscape | JD Supra
Substantial changes to the European life sciences and healthcare regulatory landscape are expected to reshape the sector. EU regulators have outlined a raft of reforms to modernise regulatory architecture, simplify product approval processes, enhance patient safety, and improve access to innovative health products.
French commission of inquiry publishes report on medicinal product shortages and pharmaceutical industry choices (France)
To access this resource, sign up for a free trial of Practical Law.
Government publishes list of essential medicines to help curb growing shortage problems (France)
The French government has announced a list of critical medicines that aims to better address shortages, and plan for reinforcement of French industrial capacity in the pharmaceutical sector.
New specifications issued on experimentation to improve access to innovative medicinal products (France)
A new French experimentation to improve access to innovative medicinal products, known as the direct access scheme, allows for derogative reimbursement of innovative medicines not eligible for early access. A recent decree and order specify its implementing framework.
French Law to regulate social media influencers' activities in bid to combat abuses on social networks (France)
A new French law, enacted on 9 June 2023, introduces new requirements applicable to social media influencers and places restrictions on their promotional activities, including with respect to health products such as medicines.
Clarification on compassionate use framework applicable to medicines subject to very early-stage clinical studies (France)
A recent decree allows for the maintaining of a compassionate use authorisation granted for medicines subject to very early clinical studies, in the absence of submission for an early access authorisation. The authorisation can be maintained for a maximum period of one year to ensure continuity of care for specific patients. Free Practical Law trial To access this resource, sign up for a free trial of Practical Law. Already registered? Sign in to your account. Contact us
New open access platform with medicinal product information from five French databases launched (France)
A new open access platform has been launched by the French National Agency for the Safety of Medicines and Health Products. The platform, which centralises data on medicinal products from five existing French databases, aims to increase transparency and access to information.
EU MDR Transitional Provisions Officially Extended | JD Supra
The revised provisions provide medical device and in-vitro diagnostics manufacturers with additional time to bring their product into compliance with the new EU Regulations, subject to a number of conditions. On March 20, 2023, Regulation (EU) no 2023/607 was published in the Official Journal of the European Union, following speedy adoption by the European Parliament and Council.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Alexandra
Contact Alexandra, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack